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Introduction
============

Infective endocarditis (IE) due to group A, B, C, or G streptococci, including the Streptococcus anginosus group (S.constellatus, S. anginosus, and S. intermedius) is relatively rare \[[@REF1]\]. IE due to group A β-hemolytic streptococcus (Streptococcus pyogenes) has rarely been reported in the literature. We herein report a Streptcoccus pyogenes native mitral valve endocarditis in a young patient along with a review of the literature.

Case presentation
=================

A 16-year-old Italian boy was admitted with a seven-day history of persistent fever and chills associated with painful swelling of the right shoulder and pharyngitis. He had previously received four days of cefixime and azithromycin treatment. He did not report any recent dental treatment, surgery, or drug abuse. His past cardiac history was unremarkable. The patient was in good general conditions and had normal vital signs (blood pressure: 125/65 mmHg, regular heart rate: 84 beats/minute). He had a temperature of 100.4°F (38°C). Cardiovascular examination revealed a systolic heart murmur 2/6 at the mesocardium. The pharynx was normal and minimal acne was observed on the skin. Blood tests indicated neutrophilic leukocytosis (white blood cell count: 13x 103/µL; neutrophils: 9.7x103/µL) as well as elevated lactate dehydrogenase (266 mU/mL) and C reactive protein (CRP; 18 mg/dL). The urine analysis was negative for infection. The electrocardiography (ECG) demonstrated sinus tachycardia, and the chest x-ray was normal. A bone marrow aspirate was performed to exclude hematological malignancies. Two sets of blood cultures were drawn, and empirical treatment with amoxicillin/clavulanate plus vancomycin was started. Blood cultures were found to be positive for gram-positive cocci in chains, which were later identified as streptococcus group A (Streptococcus pyogenes). The patient was admitted to the Infectious Disease Department and ceftriaxone (2g, twice daily) plus ampicillin (12g/day) were started. The transesophageal echocardiogram (TEE) documented moderate mitral regurgitation and multiple mobile filamentous structures attached to the posterior mitral leaflet (PML) of 1.1 cm in length suggestive of vegetation (Figure [1A](#FIG1){ref-type="fig"}-[1I](#FIG1){ref-type="fig"}).

![Sequential echocardiographic assessments\
Panel A: Transthoracic two-dimensional echocardiography -- parasternal short axis view of the mitral valve. Arrow showing vegetation on the medial portion of the posterior mitral leaflet (P3). Panel B: Transthoracic two-dimensional echocardiography -- parasternal long axis view. Arrow showing vegetation on the posterior mitral leaflet. Panel C: Transthoracic two-dimensional echocardiography -- parasternal long axis view with color flow mapping displaying a mild mitral valve regurgitation. Panel D: Three-dimensional transesophageal view of the mitral valve. Arrow showing vegetation on the posterior mitral leaflet. Panel E: Transesophageal off-axis view of the mitral valve. Arrow showing vegetation on the posterior mitral leaflet. Panel F: Transesophageal off-axis view of the mitral valve with color flow mapping showing a moderate mitral regurgitation (vena contracta width 4.87 mm). Panel G: Transthoracic two-dimensional echocardiography -- parasternal short axis view of the mitral valve. Resolution of the vegetation that was detected at the P3 level. Panel H: Transthoracic two-dimensional echocardiography -- apical two chamber view. Anterior and posterior mitral leaflets appear intact without vegetation. Panel I: Transthoracic two-dimensional echocardiography -- parasternal short axis view of the mitral valve with color flow mapping showing mild residual mitral regurgitation.\
Abbreviations: AML, anterior mitral leaflet; LA, left atrium; LV, left ventricle; PML, posterior mitral leaflet. P1 (lateral), P2 (middle), and P3 (medial) are the scallops of the posterior mitral leaflet.](cureus-0011-00000004461-i01){#FIG1}

The hemodynamic stability of the patient (he had normal values for atrial natriuretic peptide and no signs of heart failure) and the short course of antibiotic treatment were the reasons for not performing urgent surgery on the mitral valve after consultation with cardiac surgeons. Gentamicin (3mg/kg daily) was started instead of ceftriaxone on day seven. His abdominal ultrasonography was negative for liver or splenic embolisms. Painful erythematous nodules (2 to 3mm) were observed on the skin of the right sole, suggestive of secondary lesions. No other skin lesions appeared during the following days, and the neurological examination was steadily normal. The patient underwent weekly ECG evaluations during antibiotic treatment.

A second TEE done on the 12th day of antibiotic therapy found worsening of the endocarditis and growth of the vegetative lesions on the PML. On the 14th day, a cardiac magnetic resonance scan excluded either concomitant rheumatic heart disease or peri-valvular abscess due to Streptococcus pyogenes. At the ECG exams on the 19th and 25th days of hospitalization, the vegetant lesions were not observed (Figure [1](#FIG1){ref-type="fig"} G-I). Gentamicin treatment was continued for two weeks, ampicillin for four weeks, and then the patient was discharged. At the clinical control checkup six months later, the patient was asymptomatic with normal vital signs. A blood test revealed normal white blood cells (WBC) count and CRP levels. Transthoracic echocardiography (TTE) showed a low-grade mitral insufficiency consistent with previous endocarditis of posterior commissure of the mitral valve with normal left ventricular ejection fraction.

Discussion
==========

Group A β-hemolytic Streptococcus pyogenes colonizes the throat and/or skin, and it is responsible for several purulent infections including pharyngitis, impetigo, necrotizing fasciitis, and streptococcal toxic shock syndrome \[[@REF1]\]. Bloodstream infections caused by Streptococcus pyogenes come from a primary source that may be cellulitis, pharyngitis, endometritis, pneumonia, or other localized pyogenic infections \[[@REF1]\].

In our case, the source of bacteremia may have been an upper respiratory tract infection, pharyngitis, or skin lesions (acne, folliculitis). Group A Streptococcus pyogenes may induce autoimmune diseases such as acute post-streptococcal glomerulonephritis, rheumatic fever, and rheumatic heart disease; IE has rarely been reported. Based on this, a literature research was performed using PubMed without restriction on search dates. Reports were identified on PubMed using the following keywords: \'infective endocarditis and Streptococcus pyogenes\' or \'Streptococcus pyogenes endocarditis\'. The literature search was limited to English language articles. Studies not available online were excluded.

Globally, including the present case, 39 cases of endocarditis caused by Streptococcus pyogenes in children and adults have been reported since 1940 \[[@REF2]-[@REF14]\] (Table [1](#TAB1){ref-type="table"}).

###### Streptococcus pyogenes endocarditis cases from the literature review

Abbreviations: ARDS, acute respiratory distress syndrome; CHF, chronic heart failure; Heart valves: A, aortic; M, mitral; T, tricuspid; n.d., no data.

  ----------------- ------ ---------------- -------------------------------------------------------------------------- ------------------------------------- ---------------- ---------------------------- ------------------------------------------------------------------- --------------------------------------------------------------- --------- -----------
  CASE              YEAR   Age (y)/gender   PRE EXISTING CARDIAC ABNORMALITIES                                         PRECEDING INFECTION                   VALVE AFFECTED   EMBOLI                       COMPLICATIONS                                                       THERAPY                                                         SURGERY   OUTCOME
  1 \[[@REF2]\]     1942   2/M              none                                                                       none                                  M                brain, renal, skin, spleen   splenomegaly, pneumonia                                             not available                                                   no        death
  2 \[[@REF3]\]     1961   25/M             none                                                                       none                                  A+M              spleen                       kidney abscess                                                      not available                                                   no        death
  3 \[[@REF2]\]     1975   6 months/M       none                                                                       meningitis                            A+M              none                         aortic failure                                                      penicillin G                                                    no        recovered
  4 \[[@REF2]\]     1976   14/M             ventricular septal defect, aortic stenosis                                 tonsillitis                           A                none                         myocardial abscess                                                  not available                                                   no        death
  6 \[[@REF2]\]     1980   16/M             none                                                                       pharyngitis                           A                renal, peripheral            ARDS                                                                not available                                                   no        recovered
  7 \[2             1984   2/M              pulmonary artery stenosis                                                  pharyngitis                           A+M              brain, spleen                cardiac failure                                                     penicillin G; nafcillin and gentamicin                          no        death
  8 \[[@REF2]\]     1988   4/M              none                                                                       varicella                             A                none                         para-aortic abscess                                                 cefuroxime, cefaclor, ampicillin and gentamicin                 no        death
  9 \[[@REF2]\]     1988   4/F              none                                                                       none                                  A                none                         polyarthritis                                                       cefotaxime, penicillin G                                        yes       recovered
  10 \[[@REF4]\]    1991   63/F             none                                                                       pharyngitis                           none             none                         none                                                                penicillin G and penicillin V                                   no        recovered
  11 \[[@REF4]\]    1991   65/M             coronary-artery disease and severe arteriosclerosis                        arthritis, cellulitis                 M                brain, Janeway lesions       none                                                                penicillin G and penicillin V                                   no        recovered
  12 \[[@REF4]\]    1991   69/F             aortic- and pulmonary-valve prostheses                                     none                                  none             skin, roth lesion            none                                                                vancomycin and gentamicin                                       no        recovered
  13 \[[@REF4]\]    1991   55/M             mitral regurgitation                                                       none                                  M                none                         none                                                                cefazoline, ampicillin, penicillin V                            no        recovered
  14 \[[@REF2]\]    1992   3/F              none                                                                       none                                  M                brain, skin                  left-side hemiparesis, pericardial effusion, mitral regurgitation   penicillin G                                                    no        recovered
  15 \[[@REF2]\]    1994   20/M             none                                                                       none                                  M                none                         none                                                                not available                                                   no        death
  16 \[[@REF2]\]    1998   14/M             none                                                                       none                                  M                brain                        cerebral infarction                                                 penicillin, gentamycin                                          no        recovered
  17 \[[@REF2]\]    1999   5 months/M       none                                                                       varicella                             M                skin                         respiratory failure, purpura                                        ceftriaxone and vancomycin, ampicillin, penicillin              yes       recovered
  18 \[[@REF2]\]    2000   3/M              none                                                                       varicella                             A                peripheral, skin             joint pain, aortic insufficiency, CHF                               penicillin and gentamycin                                       yes       recovered
  19 \[[@REF2]\]    2000   4/M              none                                                                       none                                  A                skin                         mitral regurgitation, necrosis of toes                              not available                                                   yes       recovered
  20 \[[@REF2]\]    2000   2/M              none                                                                       varicella                             A                brain, skin                  aortic root abscess, aortic valve perforation                       not available                                                   yes       recovered
  21 \[[@REF5]\]    2004   11/M             none                                                                       varicella                             A                brain, renal, spleen         aortic failure                                                      clarithromycin                                                  yes       recovered
  22 \[[@REF6]\]    2008   68/M             none                                                                       left lower limb weakness              A                none                         meningitis, heart-failure, sepsis                                   ceftriaxone and gentamicin                                      no        death
  23 \[[@REF7]\]    2012   71/M             hypertension                                                               none                                  A, M, T          renal, spleen                aortic regurgitation, coronary artery disease                       penicillin G                                                    yes       recovered
  24 \[[@REF2]\]    2014   6/F              patent foramen ovale, atrial septal defect                                 erythematous rash, pharyngitis        A, M             skin, brain                  aortic root abscess, arrhythmia                                     ceftriaxone, vancomycin and meropenem, and gentamycin           no        recovered
  25 \[[@REF2]\]    2014   8 months/F       none                                                                       pharyngitis                           T                brain                        respiratory failure, sepsis, multi-organ failure                    penicillin and clindamycin                                      no        recovered
  26 \[[@REF8]\]    2010   64/M             none                                                                       urinary tract infection pharyngitis   none             none                         none                                                                gentamicin, benzylpenicillin                                    no        recovered
  27 \[[@REF9]\]    2017   68/M             none                                                                       arthritis                             none             none                         heart and renal failure                                             ceftriaxone, meropenem, ampicillin and clindamycin, cefazolin   no        recovered
  28 \[[@REF10]\]   2001   73/F             none                                                                       n.d.                                  A                none                         cardiac complications                                               not available                                                   no        recovered
  29 \[[@REF10]\]   2005   64/M             none                                                                       n.d.                                  A                none                         cardiac complications                                               not available                                                   yes       recovered
  30 \[[@REF10]\]   2006   33/M             none                                                                       n.d.                                  T                brain                        none                                                                not available                                                   no        recovered
  31 \[[@REF10]\]   2008   68/F             none                                                                       n.d.                                  M                none                         cardiac complications                                               not available                                                   yes       death
  32 \[[@REF10]\]   2011   24/M             none                                                                       n.d.                                  none             none                         cardiac complications                                               not available                                                   no        recovered
  33 \[[@REF10]\]   2013   39/M             none                                                                       n.d.                                  A                yes                          cardiac complications                                               not available                                                   no        death
  34 \[[@REF10]\]   2013   51/M             none                                                                       n.d.                                  A                none                         cardiac complications                                               not available                                                   yes       recovered
  35 \[[@REF11]\]   2014   5/M              none                                                                       gastroenteritis                       M                none                         none                                                                amoxicillin and gentamycin                                      no        recovered
  36 \[[@REF12]\]   2015   42/M             none                                                                       vasculitis arthritis                  T                lung, brain                  pulmonary thrombosis                                                ceftriaxone and gentamycin                                      No        recovered
  37 \[[@REF13]\]   2017   77/M             biological mitral valve prosthesis, atrial fibrillation, mellitus type 2   otitis media                          M                brain                        meningitis                                                          ceftriaxone                                                     No        recovered
  38 \[[@REF13]\]   2017   80/F             none                                                                       meningitis                            M                n.d.                         meningitis                                                          ampicillin and clindamycin                                      No        recovered
  ----------------- ------ ---------------- -------------------------------------------------------------------------- ------------------------------------- ---------------- ---------------------------- ------------------------------------------------------------------- --------------------------------------------------------------- --------- -----------

Out of the 39 cases of Streptococcus pyogenes endocarditis identified, 30 were in men (77%). Ages ranged from four months to 80 years with a median age of 32 years. Five patients were intravenous drug users. Pre-existing heart defects were known in 22.2% of the cases. Skin lesions were the predisposing infection in eight cases (20.5%), while pharyngitis was described in seven patients (18%). In four cases (10%), joint pain and arthritis were reported as the first manifestation. Ten cases (26%) had no known preceding infections. Valves on the left side were most commonly involved (88%). Embolic phenomenon occurred in 20 cases (51%) with the central nervous system and skin being the most frequent sites. Ten patients (26%) had cardiac surgery, and one of them died after surgery (10%). The mortality rate was 24% (62.5% before 1990 and 15.4% after 1990) and was mainly due to cardiac failure and/or septic shock; most patients recovered after antibiotic therapy. Compared to Streptococcus pneumonia infectious endocarditis (IE) for which the potential value of valve replacement in preventing early death has been demonstrated, in cases of Streptococcus pyogenes IE, the role for surgery is less mandatory \[[@REF15]\]. Most patients treated with antibiotic therapy alone had a favorable outcome (84%). Notably, five of the nine patients that died did so before the 1990s; the microbiological and instrumental techniques from that period are considered obsolete. Based on the limited published data, penicillin G, ampicillin, or ceftriaxone administered intravenously for four weeks are reasonable treatments for Streptococcus pyogenes IE. The addition of gentamicin to penicillin or ceftriaxone for at least the first two weeks of a four-week course of antimicrobial therapy for group B, C, and G streptococcal IE may be considered \[[@REF16]\], while another option could be daptomycin plus ampicillin based on the severity of the disease. Vancomycin is reasonable only for patients who are unable to tolerate a beta-lactam antibiotic \[[@REF16]\]. In the present case, gentamicin was added to a beta-lactam antibiotic when the echocardiographic images showed the presence of multiple vegetant lesions on the mitral valve.

Streptococcus pyogenes can also produce multiple exotoxins that have the potential to cause end-organ damage or trigger the release of cytokines that can cause tissue injury. Many virulence determinants have been identified using genomic and molecular analyses of Streptococcus pyogenes strains, many of which are related to the processes of adhesion and colonization, innate immune resistance, and the ability to facilitate degradation of tissue barriers and spread in the human body \[[@REF17]\]. The key factor of the pathogenicity of Streptococcus pyogenes is the M protein: this surface-exposed antigenic protein is involved in the adhesion of the bacterium to human tissues and in preventing phagocytosis. The Streptococcus pyogenes strain G773 was sequenced in a case of acute endocarditis in a child \[[@REF11]\]. This strain possesses a combination of various pathogenetic factors: the M protein is able to bind the C4b-binding protein and immunoglobulin; produces bacteriocins (proteins with bactericidal activity); and has the capacity to colonize the host by eliminating other bacterial species that share the same environment. In seven cases of endocarditis due to Streptococcus pyogenes, fibronectin and fibrinogen-binding genes correlated with the severity of disease manifestations such as an acute onset of illness, large vegetations, the presence of frequent embolic complications, and a high mortality rate. The Streptococcus pyogenes endocarditis strains showed an overrepresentation of several of the fibronectin and fibrinogen binding genes, which probably indicates that the ability to bind the fibronectin is an important step in the development of endovascular streptococcal infections \[[@REF10]\].

Conclusions
===========

When treated with appropriate antimicrobial therapy and supportive therapy promptly, even a severe presentation of Streptococcus pyogenesendocarditis can have excellent outcomes. In our case, antibiotic treatment was associated with clinical recovery. However, because of the relative infrequency of IE caused by Streptococcus pyogenestogether with the lack of studies in children, decisions regarding surgical intervention are best individualized. Epidemiological data and more extensive characterization of virulence factors with a genomic analysis of isolated bacteria and molecular screening are both necessary to further elucidate the pathogenic mechanisms.
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